Edge Capital Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,958
Closed -$230K 304
2023
Q3
$230K Sell
3,958
-19,376
-83% -$1.19M 0.01% 265
2023
Q2
$1.49M Buy
23,334
+992
+4% +$66.5K 0.09% 149
2023
Q1
$1.55M Buy
22,342
+18,978
+564% +$1.34M 0.1% 141
2022
Q4
$242K Sell
3,364
-279
-8% -$21K 0.02% 262
2022
Q3
$259K Sell
3,643
-125
-3% -$9.07K 0.02% 244
2022
Q2
$290K Buy
3,768
+761
+25% +$58K 0.03% 232
2022
Q1
$220K Sell
3,007
-1,186
-28% -$79.6K 0.02% 271
2021
Q4
$261K Buy
4,193
+698
+20% +$40.9K 0.02% 245
2021
Q3
$207K Hold
3,495
0.02% 265
2021
Q2
$234K Sell
3,495
-860
-20% -$56.1K 0.02% 242
2021
Q1
$275K Buy
4,355
+100
+2% +$6.22K 0.02% 234
2020
Q4
$264K Sell
4,255
-1,691
-28% -$104K 0.02% 222
2020
Q3
$358K Buy
5,946
+60
+1% +$3.61K 0.04% 181
2020
Q2
$346K Buy
5,886
+1,578
+37% +$94.4K 0.04% 177
2020
Q1
$240K Buy
4,308
+197
+5% +$12K 0.03% 186
2019
Q4
$264K Buy
+4,111
New +$235K 0.03% 205
2019
Q3
Sell
-5,766
Closed -$261K 231
2019
Q2
$261K Buy
5,766
+914
+19% +$42.6K 0.03% 224
2019
Q1
$231K Sell
4,852
-595
-11% -$29.6K 0.02% 219
2018
Q4
$283K Buy
+5,447
New +$293K 0.03% 204

Other funds holding BMY

Edge Capital Group's BMY Position: Q4 2023 in Review

Edge Capital Group sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 3,958 shares — an estimated $230K sold.

Edge Capital Group first reported a position in BMY in Q4 2018 and held it in 19 quarters. The position peaked at $1.55M in Q1 2023. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

  • Edge Capital Group reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
  • Edge Capital Group sold 3,958 Bristol-Myers Squibb shares in Q4 2023, an estimated $230K.
  • Edge Capital Group first reported a position in Bristol-Myers Squibb in Q4 2018 and held it in 19 quarters.
  • Edge Capital Group's Bristol-Myers Squibb position peaked at $1.55M in Q1 2023.
  • 2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Edge Capital Group's 13F filing for Q4 2023, filed 13 Feb 2024.